A citation-based method for searching scientific literature

Christopher P Denton, Dinesh Khanna. Lancet 2017
Times Cited: 853







List of co-cited articles
447 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron, Alan Tyndall, Marco Matucci-Cerinic, Raymond P Naden, Thomas A Medsger, Patricia E Carreira,[...]. Arthritis Rheum 2013
27

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron, Alan Tyndall, Marco Matucci-Cerinic, Raymond P Naden, Thomas A Medsger, Patricia E Carreira,[...]. Ann Rheum Dis 2013
19

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
E C LeRoy, C Black, R Fleischmajer, S Jablonska, T Krieg, T A Medsger, N Rowell, F Wollheim. J Rheumatol 1988
19

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Oliver Distler, Kristin B Highland, Martina Gahlemann, Arata Azuma, Aryeh Fischer, Maureen D Mayes, Ganesh Raghu, Wiebke Sauter, Mannaig Girard, Margarida Alves,[...]. N Engl J Med 2019
553
16

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Dinesh Khanna, Celia J F Lin, Daniel E Furst, Jonathan Goldin, Grace Kim, Masataka Kuwana, Yannick Allanore, Marco Matucci-Cerinic, Oliver Distler, Yoshihito Shima,[...]. Lancet Respir Med 2020
166
15

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
Keith M Sullivan, Ellen A Goldmuntz, Lynette Keyes-Elstein, Peter A McSweeney, Ashley Pinckney, Beverly Welch, Maureen D Mayes, Richard A Nash, Leslie J Crofford, Barry Eggleston,[...]. N Engl J Med 2018
257
14

Update of EULAR recommendations for the treatment of systemic sclerosis.
Otylia Kowal-Bielecka, Jaap Fransen, Jerome Avouac, Mike Becker, Agnieszka Kulak, Yannick Allanore, Oliver Distler, Philip Clements, Maurizio Cutolo, Laszlo Czirjak,[...]. Ann Rheum Dis 2017
505
14

Mapping and predicting mortality from systemic sclerosis.
Muriel Elhai, Christophe Meune, Marouane Boubaya, Jérôme Avouac, Eric Hachulla, Alexandra Balbir-Gurman, Gabriela Riemekasten, Paolo Airò, Beatriz Joven, Serena Vettori,[...]. Ann Rheum Dis 2017
268
13

Systemic sclerosis.
Yannick Allanore, Robert Simms, Oliver Distler, Maria Trojanowska, Janet Pope, Christopher P Denton, John Varga. Nat Rev Dis Primers 2015
382
12

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
Anthony J Tyndall, Bettina Bannert, Madelon Vonk, Paolo Airò, Franco Cozzi, Patricia E Carreira, Dominique Farge Bancel, Yannick Allanore, Ulf Müller-Ladner, Oliver Distler,[...]. Ann Rheum Dis 2010
744
11

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.
Dinesh Khanna, Christopher P Denton, Angelika Jahreis, Jacob M van Laar, Tracy M Frech, Marina E Anderson, Murray Baron, Lorinda Chung, Gerhard Fierlbeck, Santhanam Lakshminarayanan,[...]. Lancet 2016
349
11

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
Donald P Tashkin, Michael D Roth, Philip J Clements, Daniel E Furst, Dinesh Khanna, Eric C Kleerup, Jonathan Goldin, Edgar Arriola, Elizabeth R Volkmann, Suzanne Kafaja,[...]. Lancet Respir Med 2016
493
11

Cyclophosphamide versus placebo in scleroderma lung disease.
Donald P Tashkin, Robert Elashoff, Philip J Clements, Jonathan Goldin, Michael D Roth, Daniel E Furst, Edgar Arriola, Richard Silver, Charlie Strange, Marcy Bolster,[...]. N Engl J Med 2006
10

Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature.
M R Pokeerbux, J Giovannelli, L Dauchet, L Mouthon, C Agard, J C Lega, Y Allanore, P Jego, B Bienvenu, S Berthier,[...]. Arthritis Res Ther 2019
63
14


Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.
Jacob M van Laar, Dominique Farge, Jacob K Sont, Kamran Naraghi, Zora Marjanovic, Jérôme Larghero, Annemie J Schuerwegh, Erik W A Marijt, Madelon C Vonk, Anton V Schattenberg,[...]. JAMA 2014
397
8

Changes in causes of death in systemic sclerosis, 1972-2002.
Virginia D Steen, Thomas A Medsger. Ann Rheum Dis 2007
8

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
U A Walker, A Tyndall, L Czirják, C Denton, D Farge-Bancel, O Kowal-Bielecka, U Müller-Ladner, C Bocelli-Tyndall, M Matucci-Cerinic. Ann Rheum Dis 2007
569
7

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.
Dinesh Khanna, Cathie Spino, Sindhu Johnson, Lorinda Chung, Michael L Whitfield, Christopher P Denton, Veronica Berrocal, Jennifer Franks, Bhavan Mehta, Jerry Molitor,[...]. Arthritis Rheumatol 2020
101
7

Scleroderma.
Armando Gabrielli, Enrico V Avvedimento, Thomas Krieg. N Engl J Med 2009
7

Prediction of pulmonary complications and long-term survival in systemic sclerosis.
Svetlana I Nihtyanova, Benjamin E Schreiber, Voon H Ong, Daniel Rosenberg, Pia Moinzadeh, J Gerrard Coghlan, Athol U Wells, Christopher P Denton. Arthritis Rheumatol 2014
237
6


Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis.
Dinesh Khanna, Daniel E Furst, Philip J Clements, Yannick Allanore, Murray Baron, Lazlo Czirjak, Oliver Distler, Ivan Foeldvari, Masataka Kuwana, Marco Matucci-Cerinic,[...]. J Scleroderma Relat Disord 2017
193
6

Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis.
Vincent Sobanski, Jonathan Giovannelli, Yannick Allanore, Gabriela Riemekasten, Paolo Airò, Serena Vettori, Franco Cozzi, Oliver Distler, Marco Matucci-Cerinic, Christopher Denton,[...]. Arthritis Rheumatol 2019
43
13

Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis.
Korsa Khan, Shiwen Xu, Svetlana Nihtyanova, Emma Derrett-Smith, David Abraham, Christopher P Denton, Voon H Ong. Ann Rheum Dis 2012
128
6

Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study.
Eric Hachulla, Pierre Clerson, David Launay, Marc Lambert, Sandrine Morell-Dubois, Viviane Queyrel, Pierre-Yves Hatron. J Rheumatol 2007
147
5

Pathophysiology of systemic sclerosis: current understanding and new insights.
Maurizio Cutolo, Stefano Soldano, Vanessa Smith. Expert Rev Clin Immunol 2019
104
5


Mortality and survival in systemic sclerosis: systematic review and meta-analysis.
Manuel Rubio-Rivas, Cristina Royo, Carmen Pilar Simeón, Xavier Corbella, Vicent Fonollosa. Semin Arthritis Rheum 2014
186
5

Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
Svetlana I Nihtyanova, Alper Sari, Jennifer C Harvey, Anna Leslie, Emma C Derrett-Smith, Carmen Fonseca, Voon H Ong, Christopher P Denton. Arthritis Rheumatol 2020
61
8

Emerging targets of disease-modifying therapy for systemic sclerosis.
Elizabeth R Volkmann, John Varga. Nat Rev Rheumatol 2019
67
7

Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo-Controlled Trials.
Rajaie Namas, Donald P Tashkin, Daniel E Furst, Holly Wilhalme, Chi-Hong Tseng, Michael D Roth, Suzanne Kafaja, Elizabeth Volkmann, Philip J Clements, Dinesh Khanna. Arthritis Care Res (Hoboken) 2018
38
13

Interstitial lung disease in systemic sclerosis: a simple staging system.
Nicole S L Goh, Sujal R Desai, Srihari Veeraraghavan, David M Hansell, Susan J Copley, Toby M Maher, Tamera J Corte, Clare R Sander, Jonathan Ratoff, Anand Devaraj,[...]. Am J Respir Crit Care Med 2008
650
5

Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease.
David Roofeh, Celia J F Lin, Jonathan Goldin, Grace Hyun Kim, Daniel E Furst, Christopher P Denton, Suiyuan Huang, Dinesh Khanna. Arthritis Rheumatol 2021
46
10

Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial.
Kristin B Highland, Oliver Distler, Masataka Kuwana, Yannick Allanore, Shervin Assassi, Arata Azuma, Arnaud Bourdin, Christopher P Denton, Jörg H W Distler, Anna Maria Hoffmann-Vold,[...]. Lancet Respir Med 2021
48
10

Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.
Dinesh Khanna, Donald P Tashkin, Christopher P Denton, Elisabetta A Renzoni, Sujal R Desai, John Varga. Am J Respir Crit Care Med 2020
56
8

Systemic sclerosis-associated interstitial lung disease.
Apostolos Perelas, Richard M Silver, Andrea V Arrossi, Kristin B Highland. Lancet Respir Med 2020
92
5

Digital ulcers in systemic sclerosis.
Michael Hughes, Ariane L Herrick. Rheumatology (Oxford) 2017
87
5

Systemic sclerosis: a prototypic multisystem fibrotic disorder.
John Varga, David Abraham. J Clin Invest 2007
807
5

Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
Richard K Burt, Sanjiv J Shah, Karin Dill, Thomas Grant, Mihai Gheorghiade, James Schroeder, Robert Craig, Ikuo Hirano, Karin Marshall, Eric Ruderman,[...]. Lancet 2011
312
5

The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis.
Dinesh Khanna, Veronica J Berrocal, Edward H Giannini, James R Seibold, Peter A Merkel, Maureen D Mayes, Murray Baron, Philip J Clements, Virginia Steen, Shervin Assassi,[...]. Arthritis Rheumatol 2016
78
6

Treatment Algorithms for Systemic Sclerosis According to Experts.
Andreu Fernández-Codina, Kyle M Walker, Janet E Pope. Arthritis Rheumatol 2018
109
5

The pathogenesis of systemic sclerosis.
Tamiko R Katsumoto, Michael L Whitfield, M Kari Connolly. Annu Rev Pathol 2011
187
5

Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis.
Anders H Tennøe, Klaus Murbræch, Johanna C Andreassen, Håvard Fretheim, Torhild Garen, Einar Gude, Arne Andreassen, Svend Aakhus, Øyvind Molberg, Anna-Maria Hoffmann-Vold. J Am Coll Cardiol 2018
49
8

Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
Christopher P Denton, Voon H Ong, Shiwen Xu, Haiyin Chen-Harris, Zora Modrusan, Robert Lafyatis, Dinesh Khanna, Angelika Jahreis, Jeffrey Siegel, Thierry Sornasse. Ann Rheum Dis 2018
81
4

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.
Donald P Tashkin, Robert Elashoff, Philip J Clements, Michael D Roth, Daniel E Furst, Richard M Silver, Jonathan Goldin, Edgar Arriola, Charlie Strange, Marcy B Bolster,[...]. Am J Respir Crit Care Med 2007
283
4

Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database.
Florian M P Meier, Klaus W Frommer, Robert Dinser, Ulrich A Walker, Laszlo Czirjak, Christopher P Denton, Yannick Allanore, Oliver Distler, Gabriela Riemekasten, Gabriele Valentini,[...]. Ann Rheum Dis 2012
194
4

Clinical differences between idiopathic and scleroderma-related pulmonary hypertension.
Micah R Fisher, Stephen C Mathai, Hunter C Champion, Reda E Girgis, Traci Housten-Harris, Laura Hummers, Jerry A Krishnan, Fredrick Wigley, Paul M Hassoun. Arthritis Rheum 2006
242
4

Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort.
Sara Jaafar, Alain Lescoat, Suiyuan Huang, Jessica Gordon, Monique Hinchcliff, Ami A Shah, Shervin Assassi, Robyn Domsic, Elana J Bernstein, Virginia Steen,[...]. Arthritis Res Ther 2021
13
30

Predictors of progression in systemic sclerosis patients with interstitial lung disease.
Oliver Distler, Shervin Assassi, Vincent Cottin, Maurizio Cutolo, Sonye K Danoff, Christopher P Denton, Jörg H W Distler, Anna-Maria Hoffmann-Vold, Sindhu R Johnson, Ulf Müller Ladner,[...]. Eur Respir J 2020
59
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.